Health
Novel antiviral drug candidate blocks SARS-CoV-2 reproduction in cells – Drug Target Review
In human cell assays, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.
Posted: 16 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
In human cells, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.
A study in human cells found that an antiviral drug candidate called PF-00835231 may be at least as potent as the drug remdesivir at blocking the reproduction of SARS-CoV-2, which causes COVID-19.
PF-00835231 was shown in preliminary research in cells – conducted by New York University Grossman…
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General14 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News19 hours agoBrisbane rising on global rankings, but still behind southern capitals